S. V. Semochkin, “Perspectives for the Use of Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in the Treatment of Multiple Myeloma”, Clinical Oncohematology, vol. 16, no. 3, pp. 229–241, Feb. 2024, doi: 10.21320/2500-2139-2023-16-3-229-241.